KARYOPHARM THERAPEUTICS INC's ticker is KPTI and the CUSIP is 48576U106. A total of 122 filers reported holding KARYOPHARM THERAPEUTICS INC in Q3 2018. The put-call ratio across all filers is 4.03 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $456,000 | -77.2% | 29,429 | -71.7% | 0.09% | -81.2% |
| Q4 2019 | $1,996,000 | +77.0% | 104,100 | -11.2% | 0.49% | +56.2% |
| Q3 2019 | $1,128,000 | -64.3% | 117,250 | -77.7% | 0.31% | -64.9% |
| Q2 2019 | $3,156,000 | +21.5% | 526,900 | +18.4% | 0.89% | +13.6% |
| Q1 2019 | $2,598,000 | -37.7% | 444,900 | 0.0% | 0.79% | -47.4% |
| Q4 2018 | $4,169,000 | -48.3% | 444,900 | -6.1% | 1.50% | -32.9% |
| Q3 2018 | $8,071,000 | +13.9% | 473,901 | +13.7% | 2.23% | +0.4% |
| Q2 2018 | $7,083,000 | – | 416,900 | – | 2.22% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Delphi Management Partners VIII, L.L.C. | 2,263,006 | $13,170,000 | 9.51% |
| Palo Alto Investors LP | 5,383,052 | $31,329,000 | 1.89% |
| Birchview Capital, LP | 246,000 | $1,432,000 | 0.97% |
| Rubric Capital Management LP | 3,375,758 | $19,647,000 | 0.55% |
| Lombard Odier Asset Management (Switzerland) SA | 1,517,804 | $8,834,000 | 0.55% |
| RICE HALL JAMES & ASSOCIATES, LLC | 1,401,861 | $8,159,000 | 0.30% |
| AlphaCentric Advisors LLC | 136,000 | $792,000 | 0.20% |
| Bridgefront Capital, LLC | 20,946 | $122,000 | 0.13% |
| Hennion & Walsh Asset Management, Inc. | 407,474 | $2,371,000 | 0.12% |
| Virtus ETF Advisers LLC | 44,364 | $258,000 | 0.11% |